Type 1 Diabetes

Researchers Make a Case for Wearable Devices for Monitoring Type 1 Diabetes

October 27th 2019, 4:00pm

Article

The results suggested that very accurate short-term prediction can be achieved by only monitoring interstitial glucose data over a very short time period and by using a low sampling frequency.

For Young Adults With Type 1 Diabetes, Insulin Costs Can Mean Chasing Benefits, Not Dreams

September 25th 2019, 11:41pm

Article

“Diabetes fully ripped my life and potential away. I always grew up thinking I would be a professional musician. I feel like I’m still mourning the loss of what my life would have been.” --Sarah Tackett, age 26

One-Third of Type 1 Diabetes Cases Misdiagnosed in Those Over Age 30

May 4th 2019, 5:00pm

Article

Older patients who are improperly diagnosed may not gain access to insulin and delivery and monitoring tools, such as pumps or continuous glucose monitoring.

JDRF Alarmed by Extension of UnitedHealthcare–Medtronic Pact to Youth With Type 1 Diabetes

February 11th 2019, 5:51pm

Article

The advocacy group said the type 1 diabetes community is concerned about the payer's decision because not every device works the same way for every person. After a 2016 policy change affecting adults, 2 pump makers pulled devices from the US market, although other innovation has continued.

Can CGM Be a Game Changer for Pilots With Type 1 Diabetes? Two Men on a Mission Say Yes

August 13th 2018, 7:40pm

Article

FAA policy on granting medical certificates to people who use insulin are based on policies created in 1949, and advocates for people with diabetes say there's been a revolution in technology and medication since then.

Rick Doubleday Outlines the Partnership Between Dexcom and Fitbit

April 12th 2018, 5:00pm

Video

Rick Doubleday, the executive vice president and chief commercial officer at Dexcom, discusses his company's new partnership with Fitbit and what patients with both type 1 and type 2 diabetes will get out of it.

JDRF Urges Payers to Allow Choice, Limit Out-of-Pocket Costs, Cover Technology

June 2nd 2017, 4:23pm

Article

The #Coverage2Control campaign begins a year after the announcement that UnitedHealth would shift most adult type 1 diabetes patients toward Medtronic technology, or require them to pay significant out-of-pocket costs. More significantly, JDRF reports payers are saying they will not fund the artificial pancreas.

JDRF Effort Creates Exercise Guidelines for Type 1 Diabetes

January 25th 2017, 9:22am

Article

Too often, experts say, fear of hypoglycemia causes those with T1D to forgo exercise, despite the benefits.